ArticleThe Lancet regional health. Western Pacific2026
Prevalence of dual sensory impairment in Australia: a nationally representative population-based survey of Indigenous and non-Indigenous Australians.
Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dual sensory impairment and health equity: evidence and gaps from the Australian Eye and Ear Health Survey.The Lancet regional health. Western Pacific · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prevalence of co-occurring vision and hearing impairment (Dual Sensory Impairment, DSI) is expected to increase with the global ageing population. This national survey aimed to assess the prevalence and risk factors for objectively measured DSI in adults. Methods: Stratified, multi-stage random cluster sampling of 30 sites was conducted. DSI cases included persons with bilateral vision impairment (presenting distance visual acuity <6/12 in the better eye) and either, any (>25 dB hearing level, dB HL, in the unaided better ear) or moderate to worse bilateral hearing impairment (>40 dB HL, unaided better ear). Findings: 4519 participants aged 50+ years underwent the eye examination and 3573 (79.1%) also completed the ear examination. Age-standardized prevalence of DSI was 2.5% for any hearing impairment, and 1.3% for moderate or worse hearing impairment. DSI prevalence for the >25 dB HL and >40 dB HL categories, increased by ∼13- and 9-fold (p < 0.0001), respectively, from 50 to 80+ years. Age and not having private health insurance were associated with greater likelihood of DSI (for any hearing impairment) in Indigenous and non-Indigenous participants. Not having private insurance accounted for 34.0% and 86.2% of the total DSI burden in non-Indigenous and Indigenous adults, respectively. In non-Indigenous adults, living in remote/very remote areas was a risk factor: OR 2.87 (95% CI 1.27-5.96). Interpretation: DSI prevalence rises sharply with age in Australian adults. Socioeconomic disadvantage and geographic inequities account for a substantial proportion of Australia's DSI burden. Funding: Australian Commonwealth Government Department of Health; Martin Lee Centre for Innovations in Hearing Health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.